Literature DB >> 11751181

Transmission of Mycobacterium tuberculosis to contacts of HIV-infected tuberculosis patients.

A C Carvalho1, K DeRiemer, Z B Nunes, M Martins, M Comelli, A Marinoni, A L Kritski.   

Abstract

We assessed the infectiousness of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative individuals with pulmonary tuberculosis (TB) in a prospective cohort study. We enrolled, evaluated, and followed 104 close contacts of HIV-seropositive pulmonary TB patients and 256 close contacts of HIV-seronegative pulmonary TB patients using a standardized questionnaire, symptom review, chest radiograph, HIV serology, and tuberculin skin testing (TST). Contacts were followed for > or = 12 mo. TB infection at enrollment was 27% (28/104) among contacts of HIV-seropositive TB patients and 35% (90/256) among contacts of HIV-seronegative TB patients (odds ratio [OR] = 0.68, 95% confidence interval [CI] 0.41 to 1.12; p = 0.130). TST conversion occurred in 21% (42/ 204) of subjects; 8% (5/63) of contacts of HIV-seropositive index cases and 26% (37/141) of contacts of HIV-seronegative index cases (OR = 0.24, 95% CI 0.09 to 0.65; p = 0.003). TB was diagnosed in nine contacts; eight were contacts of HIV-seronegative index cases. HIV seropositivity in the index case was independently associated with a lower risk of TB infection among contacts, even among household contacts younger than 15 yr of age. Contacts of HIV-seropositive persons with pulmonary TB were less likely to have a positive TST response at 1 yr of follow-up than contacts of HIV-seronegative persons.

Entities:  

Mesh:

Year:  2001        PMID: 11751181     DOI: 10.1164/ajrccm.164.12.2103078

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

Review 1.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

2.  Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township.

Authors:  Jason R Andrews; Carl Morrow; Rochelle P Walensky; Robin Wood
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

Review 3.  Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Authors:  Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

Review 4.  Old and new selective pressures on Mycobacterium tuberculosis.

Authors:  Daniela Brites; Sebastien Gagneux
Journal:  Infect Genet Evol       Date:  2011-08-17       Impact factor: 3.342

5.  What has Karonga taught us? Tuberculosis studied over three decades.

Authors:  A C Crampin; J R Glynn; P E M Fine
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

6.  Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.

Authors:  M A Pagaoa; R A Royce; M P Chen; J E Golub; A L Davidow; Y Hirsch-Moverman; S M Marks; L D Teeter; P M Thickstun; D J Katz
Journal:  Int J Tuberc Lung Dis       Date:  2015-12       Impact factor: 2.373

7.  The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts.

Authors:  Chuan-Chin Huang; Eric Tchetgen Tchetgen; Mercedes C Becerra; Ted Cohen; Katherine C Hughes; Zibiao Zhang; Roger Calderon; Rosa Yataco; Carmen Contreras; Jerome Galea; Leonid Lecca; Megan Murray
Journal:  Clin Infect Dis       Date:  2013-12-23       Impact factor: 9.079

8.  Infectiousness of HIV-Seropositive Patients with Tuberculosis in a High-Burden African Setting.

Authors:  Leonardo Martinez; Juliet N Sekandi; María E Castellanos; Sarah Zalwango; Christopher C Whalen
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

9.  Community-randomized trial of enhanced DOTS for tuberculosis control in Rio de Janeiro, Brazil.

Authors:  S C Cavalcante; B Durovni; G L Barnes; F B A Souza; R F Silva; P F Barroso; C I Mohan; A Miller; J E Golub; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2010-02       Impact factor: 2.373

10.  Comparison of mantoux and tine tuberculin skin tests in BCG-vaccinated children investigated for tuberculosis.

Authors:  Wenli Pan; Lyness Matizirofa; Lesley Workman; Tony Hawkridge; Willem Hanekom; Hassan Mahomed; Gregory Hussey; Mark Hatherill
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.